Skip to main content
. 2019 Dec 30;16:75. doi: 10.1186/s12954-019-0343-1

Table 1.

Summary of included studies

Reference no. Country Study design Diagnosis Treatment approach
Psychiatric (n = 12)
  [87] USA CS Depression Medical therapy
  [88] USA CR Substance dependence Drug treatment programme participation
  [89] Canada CR Depressed mood with anxiety, paranoia, derealisation Medical therapy, electroconvulsive treatment
  [90] Greece CR Mood disorder with manic features Medical therapy
  [91] Germany CR Mania Medical therapy
  [92] USA CR Borderline personality disorder with antisocial traits Medical therapy, education about AAS, psychotherapy
  [93] India CR Substance dependence including opioids and AAS Medical therapy for AAS and opioid withdrawal, psycho-education and relapse prevention
  [94] Ireland CR Mixed psychotic disorder Medical therapy
  [95] USA CR Acute mania Medical therapy
  [96] UK CR Psychosis with low mood Medical therapy
  [97] USA CR AAS dependence Drug treatment programme participation
  [98] USA CR AAS dependence Medical therapy
Neuroendocrine (n = 11)
  [99] Netherlands CR Hypogonadotropic hypogonadism Medical therapy
  [100] USA CR Hypogonadism Medical therapy
  [101] Malaysia CR Complete azoospermia Medical therapy
  [102] UK CR Severe hypogonadotropic hypogonadism Medical therapy
  [103] UK CS Azoospermia Advice to discontinue AAS
  [104] USA CR Impotence—reduced testicular volume on both sides and gynaecomastia on both sides Medical therapy
  [105] USA CR Azoospermia Discontinuation of all medications; medical therapy
  [106] USA RCR Azoospermia AAS cessation and medical therapy
  [107] Italy CR Hypogonadotropic hypogonadism Medical therapy following AAS discontinuation
  [108] USA CS Hypogonadism Medical therapy
  [109] USA CR Azoospermia Medical therapy
Hepatic (n = 25)
  [110] USA CR Tumour haemorrhage in liver. On second presentation: tender hepatomegaly and haemorrhage, tachycardia Surgery; instruction to discontinue AAS
  [111] Mexico CR Liver toxicity, cholestasis Medical therapy; AAS discontinued
  [112] USA CS Hepatotoxicity Medical therapy
  [113] USA CR Liver toxicity Medical therapy
  [114] USA CS Hepatotoxicity. In one case, patient suffered from renal failure. Medical therapy
  [115] Spain CS 1) Hyperechogenic lesions in the liver; 2) Acute renal failure, muscular damage, metabolic alkalosis and hypernatraemia 1) Instruction to discontinue AAS; inclusion in liver transplantation program; 2) Patient received haemodialysis; instruction to discontinue AAS.
  [116] UK CR Hepatic rupture with cardiovascular collapse, sepsis and acute renal failure Resuscitation, surgery
  [117] Germany CR Hepatocellular carcinoma. Liver was enormously enlarged Chemoembolization was declined by patient who was recommended for transplantation
  [118] Australia CR Hepatocellular carcinoma Surgery
  [119] Lebanon CR Liver injury resulting in prolonged cholestasis and acute kidney injury Advice to discontinue AAS, medical therapy, plasma exchange. Patient refused renal biopsy.
  [120] China CR Dilated cardiomyopathy and acute hepatic injury Medical therapy
  [121] Poland CR Severe intrahepatic cholestasis that developed to severe liver failure Medical therapy
  [122] UK CS Cholestasis Medical therapy
  [123] Spain CR Severe cholestatic jaundice Unclear
  [124] USA CS Severe hepatotoxicity, cholestasis Medical therapy
  [125] Netherlands CR Mild jaundice; cholestatic hepatitis identified through liver biopsy Medical therapy
  [126] UK CR Three grade II oesophageal varices Blood transfusion and sclerotherapy
  [127] Australia CR Intrahepatic cholestasis Medical therapy
  [128] USA CR Severe cholestasis and renal failure. Re-admitted with pruritus Medical therapy
  [129] Spain CR Hepatic rupture, liver failure. Hematoma of the liver Surgery
  [130] USA CR Acute, nonobstructive, intrahepatic cholestatic hepatitis Medical therapy; advice to avoid other medications
  [131] USA CR Severe jaundice, bile acid nephropathy Medical therapy, blood transfusion, AAS discontinued
  [132] Spain CS Severe cholestasis, hepatotoxicity Medical therapy followed by MARS therapy
  [133] Brazil CR Giant hepatic adenoma Surgery
  [134] Germany CR Hepatocellular carcinoma Surgery
Kidney (n = 6)
  [135] USA CR Initial diagnosis of hepatic adenomatosis (2004). On third admission, diagnosed with chronic kidney disease and coronary artery disease (2013) Advice given to discontinue AAS initially. Surgery at later presentation.
  [136] Spain CR Severe acute kidney failure with high blood pressure, anaemia and thrombocytopenia Medical therapy
  [137] Iran CR Acute renal failure; muscle injury and rhabdomyolysis Medical therapy
  [138] Brazil CS Acute kidney injury in both cases Medical therapy.
  [139] USA CR Recurrent renal infarction Medical therapy, AAS counselling
  [140] Lebanon CR Acute pancreatitis, acute renal failure and hypercalcemia. Medical therapy
Cardiovascular (n = 26)
  [141] Japan CR Cardioembolic stroke Medical therapy, AAS use discontinued
  [142] Sweden CR Intraparenchymal haemorrhage in right parietal lobe; right cortical venous thrombosis Anticoagulation therapy
  [143] UK CR Acute myocardial infarction Surgery
  [144] Egypt CR Severe toxic cardiomyopathy. Medical therapy
  [145] Canada CR Cardiomyopathy Incubation, medical therapy, resuscitation, dialysis and device implantation, addiction counselling referral
  [146] Argentina CR Posterior territory ischemic stroke. Intubation and ventilation; rehabilitation
  [147] Sweden CR Severe hypertension Aggressive treatment with intravenous drugs; AAS cessation
  [148] Turkey CR Acute coronary syndrome Medical therapy
  [149] Sweden CS

i) Occlusion of all major arteries of the leg.

ii) Arterial thrombosis:

i) Surgery

ii) Thrombolysis attempted with no improvement. Surgery performed.

  [150] Canada CR Stroke. Upon readmission 3 years later, diffused distal arterial thrombosis Medical therapy
  [151] Kuwait CR Cardiomyopathy, stroke and peripheral vascular disease Medical therapy
  [152] Portugal CR Severe toxic cardiomyopathy. Medical therapy
  [153] USA CR Myocardial infarction Medical therapy
  [154] Turkey CR Myocardial infarction Medical therapy
  [155] Greece CR Myocardial infarction Medical therapy
  [156] USA CR Acute myocardial infarction and polycythaemia Surgery, medical therapy, phlebotomy.
  [157] Portugal CR Myocardial infarction Medical therapy.
  [158] Turkey CR Acute inferior myocardial infarction, renal infarction Medical therapy, surgery
  [159] USA CR Acute myocardial infarction Medical therapy, rehabilitation
  [160] USA CR Myocardial infarction Medical therapy
  [161] Australia CR Persistent atrial fibrillation Electrical cardioversion, medical therapy.
  [162] Germany CR Severe coronary heart disease Surgery, medical therapy
  [163] UK CR Coronary thrombus Medical therapy
  [164] USA CR Cardiomyopathy, severe systolic dysfunction and Class IV heart failure. Medical therapy and device implementation until discharge.
  [165] USA CR Cardiomyopathy, acute systolic heart failure. Medical therapy, instruction not to use AAS.
  [166] Finland CS Cardiac hypertrophy Surgery, medical therapy. In one case, no treatment was reported
Musculoskeletal (n = 13)
  [167] USA CR Tear in the midsubstance of the triceps tendon. Surgery, immobilisation
  [168] Israel CR Massive rhabdomyolysis Medical therapy
  [169] Ireland CR Quadriceps tendon rupture, patella tendon rupture, distal femur fracture, patella dislocation in both legs Surgery, immobilisation, physiotherapy
  [170] Iran CR Quadriceps tendon rupture in both knees and partial rupture of triceps tendon. Surgery, immobilisation, physiotherapy
  [171] UK CR Bilateral rupture of the quadriceps tendon Surgery, immobilisation
  [172] Denmark CR Complete rupture of the extensor pollicis longus tendon. Surgery, immobilisation
  [173] Finland CR Complete bilateral quadriceps tendon rupture in both legs Surgery, immobilisation
  [174] UK CR Rupture of both quadriceps tendons Surgery, immobilisation, physiotherapy
  [175] Finland CR Bilateral distal biceps tendon avulsions Surgery, immobilisation, physiotherapy
  [176] UK CR Complete rupture of the anterior cruciate ligament Physiotherapy
  [177] UK CR Rhabdomyolysis. Initially diagnosed with musculoskeletal pain. Medical therapy
  [178] UK CR Bilateral simultaneous traumatic upper arm compartment syndromes Surgery
  [179] Italy CR Complete tear of quadriceps tendon Surgery, immobilisation, rehabilitation
Infectious (n = 7)
  [180] USA CR Abscess. Medical therapy; AAS counselling
  [181] Israel CR Full thickness skin and subcutaneous tissue necrosis Surgery
  [182] USA CR Pyomyositis Medical therapy, surgery
  [183] UK CS Injection injury Surgery, medical therapy
  [184] Turkey CR Spontaneous corpus cavernosum abscess Surgery
  [185] UK CR Necrotizing myositis Surgery, medical therapy
  [186] UK CR Abscess Surgery, medical therapy
Other (n = 8)
  [187] UK CR Chronic laryngitis Medical therapy followed by laser treatments
  [188] UK CR Hypokalaemia and metabolic alkalosis. Fluid provision
  [189] UK CR Abnormal lipid profile Advice to stop using AAS
  [190] UK CR Acute respiratory distress syndrome Intubation and ventilation; rehabilitation.
  [191] USA CR Multiple organ dysfunction syndrome, acute kidney injury and refractory supraventricular tachycardia Resuscitation, medical therapy, ventilation, haemodialysis and electrical cardioversion for different symptoms.
  [192] USA CR New onset of diabetes Medical therapy, AAS advice
  [193] Lebanon CS Spontaneous subdural haematoma Surgery
  [194] UK CR Bilateral internal laryngocoeles Medical therapy

CR case report, CS case series, RCR retrospective chart review